Full-Time

Head of Commercial Legal

Posted on 9/27/2024

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

Biotechnology
Healthcare

Senior, Expert

Villanova, PA, USA

This is an in-office role located in the Philadelphia/Radnor area.

Category
Legal
Risk & Compliance
Legal & Compliance
Requirements
  • JD degree with 10+ years of experience as in-house counsel or associate at a major law firm with a background in biotechnology, pharma or healthcare related matters. A combination of both in-house and law firm experience is a plus
  • Admitted to at least one state bar
  • Deep experience advising on relevant health care laws and regulations (e.g., FDCA, Anti-kickback, antitrust laws, and state consumer protection laws)
  • The successful candidate will demonstrate a strong commitment to ethics and integrity
  • Detailed-oriented with a high level of intellectual, professional, and interpersonal agility and flexibility
  • Excellent communication, influencing, and client service skills
  • Well-organized and hardworking, with the ability to manage numerous projects simultaneously under deadline pressure
  • Excellent analytical skills, with a strong ability to draft and review legal documents, analyze legal advice, and apply legal advice to business needs
  • Ability to form strong working relationships with all levels of management, employees, and external stakeholders while maintaining firm adherence to proper legal standards
  • Team-oriented, sound judgment, self-motivation, and willingness to take initiative
  • Location is in the Philadelphia/Radnor area
Responsibilities
  • Strategically partner for a fast-paced and growing biotechnology organization, with specific responsibility for delivering timely legal advice to the company’s Commercial, Medical Affairs, and other departments interacting with health care providers, patient groups, payers, government agencies and their employees, pharmacies, GPOs and other stakeholders in the healthcare ecosystem.
  • These responsibilities will include advising on:
  • Promotional efforts
  • Medical Affairs activities
  • External events arranged or attended by client groups, such as conferences, seminars, etc.
  • Compliance with government price reporting requirements, government pricing negotiations and health technology assessment procedures
  • Patient support and reimbursement programs
  • Conduct of advisory boards and speaker programs
  • Advising on patient advocacy and patient organizations
  • Competition related issues
  • Review scientific publications, press releases, scripts, slide decks and other materials that reference the company’s products or product candidates
  • Advise commercial leaders and members of the global commercial leadership team
  • Provide mentorship and supervise a legal and compliance team based in Zug, Switzerland
  • Manage contracting for managed care, commercial distribution, commercial vendors, and other contracts for client groups
  • Provide advice and recommendations for pricing and reimbursement arrangements, including US government price reporting
  • Monitor and advise on relevant legal developments, trends, and risks affecting the business and the industry
  • Build and improve processes and systems to enhance the efficiency and effectiveness of the commercial legal function
  • Work closely and collaboratively with the company’s Chief Compliance Officer and the compliance organization
  • Some travel will be required for this role

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

2%

1 year growth

1%

2 year growth

14%
Simplify Jobs

Simplify's Take

What believers are saying

  • Cytokinetics secured $575M funding from Royalty Pharma for drug development and commercialization.
  • Positive Phase III trial results for aficamten in treating obstructive hypertrophic cardiomyopathy.
  • Increased focus on personalized medicine aligns with Cytokinetics' targeted therapies.

What critics are saying

  • Competition from Bristol-Myers Squibb's Camzyos threatens Cytokinetics' market share for aficamten.
  • Reliance on successful clinical trials means negative results could impact financial stability.
  • High drug development costs could strain financial resources if returns are not realized.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
  • The company targets niche markets like hypertrophic cardiomyopathy and amyotrophic lateral sclerosis.
  • Cytokinetics has a robust pipeline, including drugs like omecamtiv mecarbil and aficamten.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE